← Research library

Method of pharmacological correction of human work capacity in extreme situations

Patent disclosure · 2005

What the patent describes
A staged pharmacological-support method for work under extreme conditions; multiple agents are proposed at different stages.
Reported evidence
The patent organizes pharmacological support before exposure, during work and after work. It names Hypoxen, Sydnocarb, Mebix, Deltoran and ascorbate in the first phases, with symptom-dependent changes.

Reported patent results

The patent gives no measured outcomes

The accessed disclosure specifies a scheme but does not supply an extractable treatment cohort or measured comparative outcomes.

A staged pharmacological-support method for work under extreme conditions; multiple agents are proposed at different stages.

Population or model A staged pharmacological-support method for work under extreme conditions; multiple agents are proposed at different stages.

Results · Entire accessed description: staged scheme and concluding rationale.
MeasureResultComparison, timing and statistics
Clinical or performance resultsNo participant denominator, endpoint values or controlled effect estimate reported in the accessed descriptionThe claimed effectiveness is not a measured result

Hypoxen is one component of a proposed multi-agent approach. A regimen and its claimed benefits cannot be substituted for experimental or clinical data.

Source for these results ↗ · Reviewed 2026-11-06

Patent claims and provenance

Use. Hypoxen-related use under extreme conditions; patent examples are separate from controlled clinical confirmation.

A patent disclosure is not clinical proof, marketing approval or a legal opinion. Related publications and patent family members may describe the same experiments.

Publication
EA005383B1 ↗ · 2005-02-24
Earliest priority / filing
2001-12-28 / 2001-12-28
Original applicant / assignee
Федеральное Государственное Унитарное Предприятие "Центр Экстремальной Медицины"
Indexed status
Not shown; official status unverified · checked 2026-11-06
Patent family
34585798 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Method for pharmacological correction of human's efficiency under extreme conditions

Inventors: Евгений Георгиевич Жиляев; Павел Михайлович Шалимов; Дмитрий Валерьевич Глухов; Андрей Геннадьевич Жиляев; Сергей Егорович Макаров; Григорий Георгиевич Незнамов.

EA005383B1

Original patent PDF ↗

Patent collection and status interpretation →

Study limitations and source details

Study limitations

  • A patent documents a proposal, not a validated regimen, implemented service-wide doctrine or controlled trial.
  • The document cites a 1999 Academy publication by Novikov and Shustov. Its full text is unavailable here.

Source details

Patent

Claims, description, filing dates and prior-art citation reviewed.

Selected reported results and source limitations reviewed; not a complete risk-of-bias or experimental audit.

Sources checked

Citation

Patent / reported experimentsFull text available

E. G. Zhilyaev, P. M. Shalimov, D. V. Glukhov, A. G. Zhilyaev, S. E. Makarov, G. G. Neznamov. Method of pharmacological correction of human work capacity in extreme situations EA005383B1. Filed 28 December 2001; published 24 February 2005. Center for Extreme Medicine

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards